Smartleaf Asset Management LLC Raises Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Smartleaf Asset Management LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 30.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,883 shares of the company’s stock after buying an additional 435 shares during the quarter. Smartleaf Asset Management LLC’s holdings in GE HealthCare Technologies were worth $148,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. LGT Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Darwin Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC boosted its stake in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $85.41 on Friday. The firm has a 50 day simple moving average of $86.63 and a 200-day simple moving average of $86.13. The stock has a market cap of $39.06 billion, a price-to-earnings ratio of 19.73, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.